Deutsche Bank Ag\ Clear Point Neuro, Inc. Transaction History

Deutsche Bank Ag\

$287 Billion
Q3 2025

A detailed history of Deutsche Bank Ag\ transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 232,287 shares of CLPT stock, worth $3.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232,287

Previous 25,386 815.02%

Holding current value

$3.6 Million

Previous $303,000 1570.3%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$10.0 - $21.79 $2.07 Million - $4.51 Million	206,901 Added 815.02%	232,287 $5.06 Million
Q2 2025 Aug 12, 2025	BUY	$10.51 - $14.71 $211,040 - $295,376	20,080 Added 378.44%	25,386 $303,000
Q1 2025 May 09, 2025	BUY	$11.89 - $18.8 $63,088 - $99,752	5,306 New	5,306 $63,000
Q1 2024 Jun 02, 2025	BUY	$6.03 - $7.86 $83,033 - $108,232	13,770 Added 259.52%	19,076 $129,000
Q1 2024 May 15, 2024	SELL	$6.03 - $7.86 $3,370 - $4,393	-559 Reduced 2.85%	19,076 $129,000

Q4 2023 Feb 14, 2024	SELL	$4.46 - $7.07 $27,999 - $44,385	-6,278 Reduced 24.23%	19,635 $133,000
Q3 2023 Nov 09, 2023	BUY	$5.01 - $7.09 $129,824 - $183,723	25,913 New	25,913 $129,000
Q2 2022 Aug 11, 2022	SELL	$7.09 - $13.65 $44,922 - $86,486	-6,336 Reduced 56.14%	4,951 $65,000
Q1 2022 May 13, 2022	SELL	$7.8 - $11.6 $9,516 - $14,152	-1,220 Reduced 9.75%	11,287 $118,000
Q4 2021 Feb 11, 2022	BUY	$11.08 - $18.86 $6,670 - $11,353	602 Added 5.06%	12,507 $141,000
Q3 2021 Nov 04, 2021	SELL	$16.58 - $22.25 $4,377 - $5,874	-264 Reduced 2.17%	11,905 $211,000
Q2 2021 Aug 11, 2021	BUY	$17.23 - $22.77 $209,671 - $277,088	12,169 New	12,169 $232,000

Others Institutions Holding CLPT

# of Institutions

114

Shares Held

8.38M

Call Options Held

437K

Put Options Held

199K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $379M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account